Electrolyte Tablets
Natural health product licensed in Canada
- Licence holder
- TRACE MINERALS CANADA, ULC
- NPN or DIN-HM
- 80130569
- Status
- Active licence
- Licence date
- 12 April 2024
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Bisglycinate de magnésium | 7.5 mg | 7,500 µg |
| Eau de mer intérieure dessalée concentrée Source : Concentrated desalinated Inland Sea water Potency : 103 mg Chloride | Not specified | Not calculated |
| Bore Source : Citrate de bore | 0.17 mg | Not calculated |
| Laminaria digitata Source : Laminaria digitata - En entier | 16.66 mg | Not calculated |
| Chlorure (ion) Source : Chlorure de sodium | 70 mg | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 16.6 mg | Not calculated |
| Medicago sativa Source : Medicago sativa- Sommité (herbe) | 8.33 mg | Not calculated |
| Fer Source : Glycinate de fer (III) | 0.83 mg | 830 µg |
Non-medicinal ingredients
Stéarate de magnésium, Croscarmellose de sodium, Cellulose microcristalline, Hypromellose, Chlorure de sodium, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain/support normal muscle function. Source of/Provides (an) electrolyte(s) for the maintenance of good health. Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80130569
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.